自膨式颅内药物涂层支架系统

Search documents
赛诺医疗:公告自膨式颅内药物涂层支架系统目前正在注册过程中,公司尚无法预测其后续上市后的业绩情况
Mei Ri Jing Ji Xin Wen· 2025-09-01 08:20
(文章来源:每日经济新闻) 赛诺医疗(688108.SH)9月1日在投资者互动平台表示,公告自膨式颅内药物涂层支架系统目前正在注 册过程中,公司尚无法预测其后续上市后的业绩情况。 每经AI快讯,有投资者在投资者互动平台提问:在公司中报中提到"自膨式颅内药物涂层支架系统"在 2025年获得上市批准,我想问一下要是后续该产品上市了,预计会给公司带来多少营收以及利润呢? ...
当好“专业队”干好“精细活”
Su Zhou Ri Bao· 2025-06-13 00:23
Core Industry Development - The biopharmaceutical sector is identified as the "number one industry" in Suzhou and a core industry in Wuzhong District, with a complete industrial chain from early drug development to clinical research [1] - Wuzhong District has developed a strong innovation cluster in biopharmaceuticals, becoming a comprehensive R&D hub in the Yangtze River Delta region [1] Regulatory Support and Services - Wuzhong District's market supervision bureau has implemented tailored services for biopharmaceutical companies, facilitating faster product approvals, exemplified by the approval of a unique pain relief gel by Leming Pharmaceutical [2][3] - The district has established a "white list" system to address import difficulties for R&D materials, enhancing the development capabilities of local biopharmaceutical firms [3] Knowledge and Intellectual Property Protection - The district has strengthened intellectual property protection, increasing funding for biopharmaceutical innovation, with a 30% increase in rewards for patent achievements [5] - A rapid patent review process has been introduced, reducing the time for patent approval from two years to as little as two to three months, benefiting 104 local biopharmaceutical companies [6] Quality Assurance and Standards - Wuzhong District has launched initiatives to enhance quality standards in the biopharmaceutical industry, including the establishment of a quality empowerment station to provide comprehensive services [7] - The district has published a white paper on the standardization of the biopharmaceutical and health industry, clarifying development paths and directions [7] Future Plans and Strategic Development - The market supervision bureau plans to create a database of certified biopharmaceutical companies and develop service lists for major projects and key enterprises to improve service precision and effectiveness [8]